Prometic is an established biopharmaceutical company www.prometic.com with widely recognized expertise in bioseparations, plasma derived therapeutics and small molecule therapeutics development. Prometic offers its bioseparation technologies and expertise for large scale purification of biologics, drug development, proteomics and the elimination of pathogens to industry leaders and uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma to develop and commercialize plasma derived therapeutics. Prometic is also active in developing its own novel small molecule therapeutic products targeting unmet medical needs in the fields of fibrosis, targeting, inter alia, the lungs, liver, heart and kidney as well as diabetes, anemia and autoimmune diseases. Headquartered in Laval Canada , Prometic has R amp D facilities in the United Kingdom, the United States and Canada, manufacturing facilities in the UK and Canada and corporate and business development activities in the UK, Canada, USA and Europe. Prometic s common shares trade on the Toronto Stock Exchange TSX under the symbol PLI and the OTCQX International under the symbol PFSCF.
Quote | Liminal Biosciences Inc - Ordinary Shares (OTCMKTS:PFSCF)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $5.467 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 12/25/2019 04:57:15 pm |
News | Liminal Biosciences Inc - Ordinary Shares (OTCMKTS:PFSCF)
LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, UK , Nov. 18, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biotechnology company focused on developing novel therapeutics to treat unmet needs ...
LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, United Kingdom , Nov. 18, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biotechnology company focused on developing novel therapeutics to treat unmet needs in p...
Message Board Posts | Liminal Biosciences Inc - Ordinary Shares (OTCMKTS:PFSCF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Liminal Biosciences Inc - Ordinary Shares Company Name:
PFSCF Stock Symbol:
OTCMKTS Market:
LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, UK , Nov. 18, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biotechnology company focused on developing novel therapeutics to treat unmet needs ...
LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, United Kingdom , Nov. 18, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biotechnology company focused on developing novel therapeutics to treat unmet needs in p...
Liminal BioSciences to Present at Stifel Healthcare Conference Canada NewsWire LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Nov. 15, 2019 LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, United Kingdom , Nov. 15, 2019 /CNW Telbec/ - Liminal BioSciences Inc. (TS...